Novartis Investigation Confirms Conflict Of Interest in Diovan Trial; Japan Health Ministry Looking For More
This article was originally published in PharmAsia News
Executive Summary
The third-party investigation into Japan trials of Diovan reveals no evidence of “willful manipulation” of data, but MHLW may look further into the trials.